193 related articles for article (PubMed ID: 22562854)
1. Harnessing academia, government, and industry.
Tumminia SJ
Invest Ophthalmol Vis Sci; 2012 May; 53(5):2515-21. PubMed ID: 22562854
[No Abstract] [Full Text] [Related]
2. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
3. Reaping the benefits of biomedical research: partnerships required.
Portilla LM; Alving B
Sci Transl Med; 2010 Jun; 2(35):35cm17. PubMed ID: 20538616
[TBL] [Abstract][Full Text] [Related]
4. Advancing translational research collaborations.
Portilla LM; Evans G; Eng B; Fadem TJ
Sci Transl Med; 2010 Dec; 2(63):63cm30. PubMed ID: 21178130
[TBL] [Abstract][Full Text] [Related]
5. The need for private-public partnerships.
Nat Med; 2000 May; 6(5):481. PubMed ID: 10802675
[No Abstract] [Full Text] [Related]
6. New NIH center broadens scope of translational research.
Jenks S
J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
[No Abstract] [Full Text] [Related]
7. Why does the United States need a national center for new cures?
Licinio J; Wong ML
Mol Psychiatry; 2011 Sep; 16(9):882-4. PubMed ID: 21866106
[No Abstract] [Full Text] [Related]
8. High stakes for US science.
Tollefson J; Ledford H
Nature; 2012 Oct; 490(7421):453-5. PubMed ID: 23099376
[No Abstract] [Full Text] [Related]
9. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
10. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
11. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement.
Biotechnology Industry Organization
J Biolaw Bus; 1999; 3(1):40-4. PubMed ID: 11933970
[TBL] [Abstract][Full Text] [Related]
12. New and evolving rare diseases research programs at the National Institutes of Health.
Groft SC; Rubinstein YR
Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
[TBL] [Abstract][Full Text] [Related]
13. Policy directions for the National Heart, Lung, and Blood Institute: implications for academia and industry.
Lenfant C
Circulation; 1985 Aug; 72(2 Pt 2):I44-7. PubMed ID: 4006158
[No Abstract] [Full Text] [Related]
14. Partnerships in drug abuse prevention services research: perspectives from the National Institute on Drug Abuse.
Robertson EB; Sims BE; Reider EE
Adm Policy Ment Health; 2012 Jul; 39(4):327-30. PubMed ID: 22203328
[No Abstract] [Full Text] [Related]
15. Taking the profit out of biomedical research tools.
Flores MA
Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
[TBL] [Abstract][Full Text] [Related]
16. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse.
Blaug S; Chien C; Shuster MJ
Nat Biotechnol; 2004 Jun; 22(6):761-4. PubMed ID: 15175696
[No Abstract] [Full Text] [Related]
17. Development of vaccines to meet public health needs: incentives and obstacles.
Russell PK
Risk; 1996; 7(3):239-52. PubMed ID: 11655077
[No Abstract] [Full Text] [Related]
18. An audience with...Francis Collins. Interviewed by Asher Mullard.
Collins F
Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
[No Abstract] [Full Text] [Related]
19. Brain wave hits California.
Shen H
Nature; 2014 Jun; 510(7506):456. PubMed ID: 24965632
[No Abstract] [Full Text] [Related]
20. The patient-physician-industry-government partnership: a societal good.
Frishman WH
Am J Med; 2009 Oct; 122(10):886-7. PubMed ID: 19786152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
